SCHEMBL5449752

SCHEMBL5449752

Cc1ccccc1C(=O)Nc1c2c(nn1-c1cccc(Cl)c1Cl)CSC2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
USP2 O75604 3/20 0.61
RECQL P46063 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
CYP3A4 P08684 2/20 0.61
CYP2C9 P11712 2/20 0.61
CYP2C19 P33261 1/20 0.61
MAPT P10636 2/20 0.58
THRB P10828 1/20 0.58
POLB P06746 3/20 0.58
HSD17B10 Q99714 3/20 0.58
ALDH1A1 P00352 2/20 0.58
FPR1 P21462 1/20 0.58
TSHR P16473 3/20 0.55
CYP2D6 P10635 1/20 0.54
ENPP2 Q13822 3/20 0.52
HTT P42858 1/20 0.49
PDE2A O00408 1/20 0.49
PDE6D O43924 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5446699 0.89 MEN1 (0.53) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL29835096 0.82 HTT (0.74) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL5448323 0.81 ENPP2 (0.49) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL4882118 0.80 ENPP2 (0.57) MEN1KMT2AUSP2CYP3A4CYP2C9
SCHEMBL4882902 0.78 MAPT (0.64) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL4698864 0.78 P2RX7 (0.55) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL5448123 0.76 ENPP2 (0.42) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL5476310 0.76 TSHR (0.42) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL29813896 0.75 CYP3A4 (0.70) MEN1KMT2AUSP2RECQLNPSR1
SCHEMBL833831 0.75 CYP3A4 (0.73) MEN1KMT2AUSP2RECQLNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259920-A1 P2X7, receptor antagonists and uses thereof ABBOTT LABORATORIES 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259920-A1 P2X7, receptor antagonists and uses thereof P2RX7, P2RX1, P2RX3 MEN1 3501/4885KMT2A 4301/4885USP2 4528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.